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ORIGINAL ARTICLE
Background: Whether improvement of quality of surgical cancer 
care can be achieved by centralizing care in high-volume special-
ized centers is a subject of ongoing debate. We have conducted a 
meta-analysis of the literature on the effect of procedural volume or 
surgeon specialty on outcome of lung resections for cancer.
Methods: A systematic search of articles published between January 
1, 1990 and January 20, 2011 on the effects of surgeon specialty and 
hospital or surgeon volume of lung resections on mortality and sur-
vival was conducted. After strict inclusion, meta-analysis assuming a 
random-effects model was performed. Meta-regression was used to 
identify volume cutoff values. Heterogeneity and the risk of publica-
tion bias were evaluated.
Results: Nineteen relevant studies were found. Studies were hetero-
geneous, especially in defining volume categories. The pooled esti-
mated effect size was significant in favor of high-volume hospitals 
regarding postoperative mortality (odds ratio [OR] 0.71; confidence 
interval 0.62–0.81), but not for survival (OR 0.93; confidence inter-
val 0.84–1.03). Surgeon volume showed no significant effect on out-
come. General surgeons had significantly higher mortality risks than 
general thoracic (OR 0.78; 0.70–0.88) or cardiothoracic surgeons 
(OR 0.82; 0.69–0.96). A minimal annual volume of resections for 
lung cancer could not be identified.
Conclusions: Hospital volume and surgeon specialty are important 
determinants of outcome in lung cancer resections, but evidence-
based minimal-volume standards are lacking. Evaluation of individ-
ual institutions in a national audit program might help elucidate the 
influence of individual quality-of-care parameters, including hospital 
volume, on outcome.
Key Words: Lung cancer, Quality improvement, Thoracic surgery, 
Procedural volume, Surgeon specialty. 
(J Thorac Oncol. 2012;7: 1170–1178)
Improvement of safety, quality, and increased cost-effective-ness of cancer care are a subject of ongoing debate in the 
professional, public, and political arenas in many countries. 
The outcome of high-risk, low-volume procedures, such as 
esophageal and pancreatic resections, is especially thought 
to improve when centralized in high-volume specialized 
centers.1,2 One of the parameters that is frequently suggested 
in guiding this centralization process is procedural volume. 
Introduction of minimal volume standards to impose central-
ization might be appealing to policy makers, because it is a 
clear and easily enforceable parameter. Because many fac-
tors—for example, patient selection, perioperative care pro-
tocols, and dedicated nursing staff—influence the outcome of 
low-volume, high-risk surgical cancer care, the emphasis of 
governing bodies on hospital-volume criteria seems too lim-
ited when the quality of research supporting these criteria is 
substandard.
Even though the annual case-load is larger than that of 
pancreatic or esophageal cancer, lung cancer surgery is also 
deemed to be a low-volume, high-risk surgery. There is, how-
ever, limited evidence to support volume standards in lung 
cancer surgery.
The methodological quality of volume-outcome studies 
is sometimes disputable and no meta-analysis is yet available. 
The vast majority of studies is observational and based on 
administrative data collected for other purposes. Differences 
in case mix are not always accounted for, and postoperative 
mortality is often presented as the sole outcome measure. 
These inadequate reports only feed an endless debate and 
hamper the introduction of minimal-volume standards in sev-
eral countries, including The Netherlands.3
The aim of this study was to contribute to the ongoing 
debate by conducting a systematic review and meta-analysis 
of methodologically high-quality studies on the relationship 
between hospital volume, surgeon volume, and surgeon spe-
cialization on mortality and survival after lung resections.
METHODS AND MATERIALS
Systematic Search Strategy
We performed a systematic search to identify articles 
published after January 1, 1990, which described the 
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association between surgeon specialty, surgeon volume or 
hospital volume of lung resections and postoperative mortality 
and survival. The search was conducted in the Medline 
database (PubMed) and Cochrane library with a combination 
of MESH terms and text words (Table 1). Because volume 
is not well indexed in electronic databases, we formulated 
the search terms to be as sensitive as possible to ensure no 
publications were missed. The last search was conducted on 
January 20, 2011.
Study Selection
Two reviewers (G.G. and E.v.M.) independently 
screened titles and abstracts of all retrieved articles. Studies 
were selected using the following inclusion criteria:
•  Written in English.
•  Primary data.
•  Subject: surgical treatment of lung cancer.
•  Comparisons between providers (hospitals or surgeons).
•  No single-hospital nor single-surgeon studies.
•  Postoperative mortality or survival as outcome 
parameters.
•  Distinct cutoff value for procedural volume or clearly 
defined specialty.
After this first selection on the basis of titles and abstracts, the 
remaining articles were obtained in full text and were further 
selected by the same reviewers. Any discrepancies regarding 
inclusion of a study were solved by consensus after discussion 
with a third author (M.W. or P.P.). Reference lists of relevant 
articles and recent reviews were hand-searched to identify 
additional articles. We also used the “related articles” function 
in PubMed.
The following information was retrieved from the 
selected articles and entered in our database: year of publica-
tion, country, data source, study period, number of patients, 
hospitals and surgeons, surgeon specialty, case-mix adjust-
ments, volume categories for hospitals, volume categories for 
surgeons, outcome parameters (mortality and survival), and 
results regarding these outcome parameters (statistically sig-
nificant or nonsignificant).
Assessment of Study Quality
Two authors (E.v.M. and G.G.) critically appraised each 
study in the review on methodological quality and multiple use 
of the same database. Data were gathered in a data-extraction 
form, which was based on the Strengthening the Reporting of 
Observational studies in Epidemiology criteria (www.strobe-
statement.org).
Study inclusion criteria were checked for probability 
of selection bias. When multiple use of the same database 
was established, the study with the largest patient cohort was 
used. Cutoff values for high- and low-volume were noted per 
volume group. The study results were recorded separately for 
each unit (surgeon, surgeon specialty, or hospital) and for each 
outcome parameter (postoperative mortality and long-term 
survival). Subsequently, we noted the estimated effect size 
after adjustment comparing the highest volume group with 
the lowest, expressed as odds ratios (OR), hazard ratios (HR), 
or risk rates (RR) with confidence intervals (CI). If necessary, 
we converted the effect sizes so that the lowest-volume group 
was the reference in all studies. Studies without a multivariate 
analysis and/or no reporting of OR, HR, or RR were excluded 
from the meta-analysis.
Synthesis of the Data for Meta-Analysis
A meta-analysis was performed for the relationship 
between hospital volume, surgeon volume, and surgeon spe-
cialty on the one hand and postoperative mortality and long-term 
survival on the other. The random-effect model, which accounts 
for the expected heterogeneity in pooling observational studies, 
TABLE 1.  Search Terms Used; Last Search January 20, 2011
Medline (PubMed) 
((“Pneumonectomy “[majr] OR “ Lung Neoplasms /surgery “[MAJR] 
OR (“Surgical Procedures, Operative”[MAJR:NoExp] AND 
“Neoplasms”[MAJR:NoExp])) AND (“hospital volume” OR “surgeon 
volume” OR “surgeon specialty” OR “provider volume” OR “Outcome 
Assessment (Health Care)”[MAJR] OR regionalization[ti] OR 
regionalization[ti] OR “Health Facility Size”[majr] OR “Workload”[majr] 
OR (outcome*[ti] AND volume*[ti]) OR (outcome*[ti] AND 
complication*[ti])))
FIGURE 1. Selection process of 
reviewed studies. OR, odds ratio.
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was used.4 Heterogeneity was quantified by the I2 test. An I2 
less than 40 was considered homogeneous; between 40 and 60, 
moderately heterogeneous; and greater than 60 very heteroge-
neous.5 We conducted a sensitivity analysis to assess the impact 
of subgroups in case of heterogeneity. Publication bias was 
assessed with an Egger’s regression intercept.6 Meta-regression 
analysis was done for cutoff values of hospital volume, using a 
fixed-effects regression test. The meta-analysis was conducted 
with Comprehensive Meta Analysis, professional version 2.2 
(Biostat Inc., Englewood NJ).
RESULTS
Search Results
Our initial search identified 95 potentially relevant 
articles. After the first screening, 17 articles were retrieved 
for more detailed evaluation. From these, six articles were 
excluded.7–12 The remaining 11 articles were selected. After 
this first selection, the related-articles feature in PubMed was 
used, and the reference lists of retrieved articles were hand-
searched to identify eight additional articles, which met the 
TABLE 2.  Studies Included in the Systematic Review of the Literature on the Relationship Between Volume and Outcome of  
Lung Resections for Cancer
Study Country Data Patients Hospitals Surgeons
Case-Mix Adjustment Hospital Volume Surgeon Volume Surgeon Specialty
Demographic Comorbidities Urgency Tumor Treatment Mortality Hospital
Volume  
Categories
Mortality Survival
Volume 
Categories
Mortality Survival
Surgeon 
Categories Mortality SurvivalLow High Low High
Birkmeyer  
et al.1
USA Adm 19410 1877 n.r. • • • — • — — <9 >46 S(L)  
& (P)
— — — — — — — —
Birkmeyer  
et al.2
USA Adm 24092 n.r. 4178 • • • — — — • — — — — <7 >17 NS — — — —
Sioris et al.13 Finland Adm 5339 26 n.r. • — — • • — — <5 >20 NS S — — — — — — —
Bilimoria  
et al.14
USA Adm 40754 1528 n.r. • • — • • — — <21 >83 S S — — — — — — —
Urbach et al.15 Can Adm 5156 54 n.r. • • — — — — — <18.2 >129,4 NS — — — — — — — —
Freixinet  
et al.16
Spain Clin 2994 19 n.r. • • — • • — — <44 >54 NS NS — — — — — — —
Romano and 
Mark17
USA Adm 12439 389 n.r. • • — • • — • <9 >24 S (L),  
NS (P)
— — — — — — — —
Simunovic  
et al.18
Canada Adm 2698 67 n.r. • • — • — — • <10.7 >43,7 NS S — — — — — — —
Finlayson  
et al.19
USA Adm 21890 674 n.r. • • • — • — — <19 >37 NS(L) 
&(P)
— — — — — — — —
Osada and  
Yamakoshi20
Japan Clin 3233 91 n.r. • — — • • — — <20 >79 — S — — — — — — —
Osada and  
Yamakoshi20
Japan Clin 18055 540 n.r. • — — — • — — <25. 
quartiles
>99 NS — — — — — — — —
Hollenbeck  
et al.21
USA Adm 90088 n.r. n.r. • • • — — — — <3.6 >116,3 S — — — — — — — —
Kim et al.22 South 
Korea
Adm 987 n.r. n.r. • • • — — — — <5 >20 NS — — — — — — — —
Li et al.23 Netherlands Clin 1097 20 n.r. • — — • — — • <40 >60 — NS — — — — CTS vs. GS — NS
Birkmeyer  
et al.24
USA Adm 12967 517 n.r. • • • • • • — <11.4 >25,2 — S — — — — — — —
Cheung et al25 USA Adm 13469 90 n.r. • • — • • — • <60 >60 — S — — — — — — —
Lien et al.26 Taiwan Adm 4841 79 377 • • — • • — — — — — — <11.5 >33 S — — — —
Goodney  
et al.27
USA Adm 25545 n.r. n.a. • • — — • — • — — — — — — — — 663 TS, 1516 
CTS, 2614 
GS
S —
Schipper  
et al.28
USA Adm 86538 n.r. n.a. • • — — • — • — — — — — — — — 331 TS, 3401 
CTS, 9194 
GS
S (L), NS 
(P)
—
Farjah et al.29 USA Adm 19745 n.r. n.a. • • — • • — — — — — — — — — — 388 TS, 684 
CTS, 776 GS
NS S
Adm, based on administrative data; Clin, based on clinical data; n.r., not reported; n.a., not applicable; Demographic, adjusted for demographic data (e.g., patient age, sex, race,  
and income); Comorbidities, adjusted for comorbidities (including American Society of Anesthesiologists classification); Urgency, adjusted for urgency of the operation; Tumor,  
adjusted for tumor characteristics (e.g., stage, grade, and location); Treatment, adjusted for treatment differences (e.g., surgical approach; [neo]adjuvant treatments); Mortality, s 
urvival analysis adjusted for postoperative mortality; Hospital, adjusted for other hospital characteristics (e.g., teaching or academic status); Low: <10, low-volume group < 10, High:  
>20, high-volume > 20 resections a year; S, statistically significant; NS, statistically nonsignificant; L, lesser lung resections; P, pneumonectomies; TS, general thoracic surgeon;  
CTS, cardio thoracic surgeon; GS, general surgeon.
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predefined inclusion criteria. Nineteen eligible articles were 
analyzed (Fig. 1).
Study Characteristics
Table 2 shows the characteristics of the 19 studies 
included in the review. Most studies are from the United 
States and Canada, and the remaining studies are from Asia 
and Europe. Study data have been obtained frequently from 
the databases of insurance companies or national cancer 
registries (Medicare, National Inpatient Sample). The 
number of patients, hospitals, and surgeons varied widely 
among the included studies. In all selected studies, the 
results were adjusted for differences in case mix, but the 
parameters used for the adjustments differed largely. For 
hospital volume, cutoff values of the highest volume strata 
varied between 20 and 129.4 procedures annually, and the 
lowest hospital-volume strata cutoff varied between 3.6 and 
60. The rationale for the cutoff values used varied and was 
not always explained in the sections on methodology in the 
articles.
TABLE 2.  Studies Included in the Systematic Review of the Literature on the Relationship Between Volume and Outcome of  
Lung Resections for Cancer
Study Country Data Patients Hospitals Surgeons
Case-Mix Adjustment Hospital Volume Surgeon Volume Surgeon Specialty
Demographic Comorbidities Urgency Tumor Treatment Mortality Hospital
Volume  
Categories
Mortality Survival
Volume 
Categories
Mortality Survival
Surgeon 
Categories Mortality SurvivalLow High Low High
Birkmeyer  
et al.1
USA Adm 19410 1877 n.r. • • • — • — — <9 >46 S(L)  
& (P)
— — — — — — — —
Birkmeyer  
et al.2
USA Adm 24092 n.r. 4178 • • • — — — • — — — — <7 >17 NS — — — —
Sioris et al.13 Finland Adm 5339 26 n.r. • — — • • — — <5 >20 NS S — — — — — — —
Bilimoria  
et al.14
USA Adm 40754 1528 n.r. • • — • • — — <21 >83 S S — — — — — — —
Urbach et al.15 Can Adm 5156 54 n.r. • • — — — — — <18.2 >129,4 NS — — — — — — — —
Freixinet  
et al.16
Spain Clin 2994 19 n.r. • • — • • — — <44 >54 NS NS — — — — — — —
Romano and 
Mark17
USA Adm 12439 389 n.r. • • — • • — • <9 >24 S (L),  
NS (P)
— — — — — — — —
Simunovic  
et al.18
Canada Adm 2698 67 n.r. • • — • — — • <10.7 >43,7 NS S — — — — — — —
Finlayson  
et al.19
USA Adm 21890 674 n.r. • • • — • — — <19 >37 NS(L) 
&(P)
— — — — — — — —
Osada and  
Yamakoshi20
Japan Clin 3233 91 n.r. • — — • • — — <20 >79 — S — — — — — — —
Osada and  
Yamakoshi20
Japan Clin 18055 540 n.r. • — — — • — — <25. 
quartiles
>99 NS — — — — — — — —
Hollenbeck  
et al.21
USA Adm 90088 n.r. n.r. • • • — — — — <3.6 >116,3 S — — — — — — — —
Kim et al.22 South 
Korea
Adm 987 n.r. n.r. • • • — — — — <5 >20 NS — — — — — — — —
Li et al.23 Netherlands Clin 1097 20 n.r. • — — • — — • <40 >60 — NS — — — — CTS vs. GS — NS
Birkmeyer  
et al.24
USA Adm 12967 517 n.r. • • • • • • — <11.4 >25,2 — S — — — — — — —
Cheung et al25 USA Adm 13469 90 n.r. • • — • • — • <60 >60 — S — — — — — — —
Lien et al.26 Taiwan Adm 4841 79 377 • • — • • — — — — — — <11.5 >33 S — — — —
Goodney  
et al.27
USA Adm 25545 n.r. n.a. • • — — • — • — — — — — — — — 663 TS, 1516 
CTS, 2614 
GS
S —
Schipper  
et al.28
USA Adm 86538 n.r. n.a. • • — — • — • — — — — — — — — 331 TS, 3401 
CTS, 9194 
GS
S (L), NS 
(P)
—
Farjah et al.29 USA Adm 19745 n.r. n.a. • • — • • — — — — — — — — — — 388 TS, 684 
CTS, 776 GS
NS S
Adm, based on administrative data; Clin, based on clinical data; n.r., not reported; n.a., not applicable; Demographic, adjusted for demographic data (e.g., patient age, sex, race,  
and income); Comorbidities, adjusted for comorbidities (including American Society of Anesthesiologists classification); Urgency, adjusted for urgency of the operation; Tumor,  
adjusted for tumor characteristics (e.g., stage, grade, and location); Treatment, adjusted for treatment differences (e.g., surgical approach; [neo]adjuvant treatments); Mortality, s 
urvival analysis adjusted for postoperative mortality; Hospital, adjusted for other hospital characteristics (e.g., teaching or academic status); Low: <10, low-volume group < 10, High:  
>20, high-volume > 20 resections a year; S, statistically significant; NS, statistically nonsignificant; L, lesser lung resections; P, pneumonectomies; TS, general thoracic surgeon;  
CTS, cardio thoracic surgeon; GS, general surgeon.
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Hospital Volume
Postoperative mortality was used as an outcome param-
eter in 11 studies; in five of these studies, a significant inverse 
relationship between hospital volume and 30-day or in-hospi-
tal mortality was found.1,13–22
Ten studies were used for the meta-analysis, as one did 
not provide an OR.13 All of these studies had an observational 
design, and only two studies were based on clinical data; the 
remaining eight were based on administrative data. In all but 
one, the results were adjusted not only for age and sex, but 
also for other parameters. (Table 2)
Figure 2 shows the forest plot regarding hospital vol-
ume and postoperative mortality using ORs. The effect was 
significant in favor of high-volume hospitals (OR 0.71; CI 
0.62–0.81). One study used HRs and one study used  rela-
tive risk, both favoring high hospital volume, with an HR of 
0.76 (CI 0.66–0.88) and RR of 0.83 (CI 0.59–1.25), respec-
tively.14,15 There was moderate heterogeneity between the two 
studies (I2 = 53). Subgroup analysis of the studies using ORs 
did not reveal any parameter showing significant influence on 
the pooled estimate effect size. (Table 3) No publication bias 
was detected (p = 0.36).
Regression analysis did not identify a cutoff value for 
volume of resections for lung cancer to differentiate hospitals 
with high versus low postoperative mortality rates. The p value 
for the slope is 0.73 (Fig. 3).
Differences in survival between high- and low-volume 
hospitals were evaluated in eight studies, five of which showed 
a significant inverse relationship between hospital volume and 
survival and one of which showed a significant benefit for the 
lower-volume category.13,14,16,18,20,23–25
Seven studies met the criteria for the meta-analysis, as 
one did not provide an HR.16 All studies were observational; 
two studies used clinical instead of administrative data. In all 
studies, the results were adjusted not only for age and sex, but 
also for other parameters (Table 2).
Figure 4 shows the forest plot on hospital volume 
and survival. The effect was in favor of high-volume hospi-
tals but it did not reach statistical significance (HR 0.93; CI 
0.84–1.03). This result was very heterogeneous (I2 = 85). In 
FIGURE 2.  Forest plot of the 
included studies using OR in the 
meta-analysis on hospital volume 
and postoperative mortality for lung 
resections for cancer. Separate analy-
sis of pneumonectomies and lobec-
tomies in case of sufficient data. OR, 
odds ratio; Study name, name of first 
author (resection type if specific odds 
ratios available); Year, year of publica-
tion; Low, highest annual volume of 
low-volume category; High, lowest 
annual volume of high-volume cat-
egory; CI, confidence interval.
TABLE 3. Sensitivity Analysis of the 11 Included Series on 
Hospital Volume and Postoperative Mortality with Odds 
Ratios as Effect Size
Factor Subgroup N OR CI p Value
Datasource 0.367
Administrative 9 0.69 0.60–0.79
Clinical 2 0.79 0.60–1.04
Comorbidity 0.198
Not adjusted 1 0.55 0.36–0.83
Adjusted 10 0.73 0.64–0.83
Urgency 0.810
Not adjusted 5 0.69 0.55–0.86
Adjusted 6 0.72 0.60–0.85
Tumor stage 0.367
Not adjusted 9 0.69 0.60–0.79
Adjusted 2 0.79 0.60–1.04
This (two-sided) p value is the result of the mixed-effects analysis and tells us 
whether there is a statistically significant difference in the effect between subgroups.
N, number of studies; OR, odds ratio; CI, confidence interval; I2, result of I square 
test on heterogeneity of study results.8 
FIGURE 3. Regression analysis of the effect of high proce-
dural hospital volume on hospital mortality. 
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subgroup analysis, a significant effect of hospital volume on 
survival was observed after adjustment for comorbidities (OR 
0.88; CI 0.81–0.95) (p = 0.003, Table 4). No publication bias 
was detected (p = 0.82).
Surgeon Volume
In two studies, the relationship between surgeon volume 
and outcome was investigated.2,26 Both studies used postopera-
tive mortality as an outcome parameter; one showed a significant 
result favoring high volume. Both were used for the meta-analy-
sis. Age, sex, and comorbidities were included in the multivariate 
analysis in both studies. One adjusted for tumor characteristics 
and treatment differences in its outcome analyses, the other for 
urgency of operation and other hospital characteristics.
Figure 5 shows the forest plot of the two studies. In the 
meta-analysis, a pooled estimated effect size was detected 
in favor of high-volume surgeons, but this effect did not 
reach statistical significance (OR 0.68; CI 0.42–1.08) and 
was very heterogeneous (I2 = 66). The number of studies is 
too small to properly assess publication bias or perform sub-
group analysis.
Surgeon Specialty
In three studies, the relationship between surgeon spe-
cialty and postoperative mortality was investigated.27–29 These 
studies compared three provider groups: general surgeons 
(GS), cardiothoracic surgeons (CTS), and general thoracic 
surgeons (TS). One study showed a significant difference; in 
another, the difference was significant in lobectomies, not in 
pneumonectomies. The third study did not show a significant 
difference. All three studies met the inclusion criteria for the 
meta-analysis. In all, age, sex, comorbidities, and treatment 
differences were included in the multivariate analysis. Two 
adjusted for other hospital characteristics and one adjusted 
for tumor characteristics in their survival analyses. Figures 
6A and B show the forest plots of the included studies. There 
was a significant pooled estimated effect size in favor of TS 
over GS (OR 0.78; 0.70–0.88), and of CTS over GS (OR 
0.82; CI 0.69–0.96). As a result of the lack of ORs compar-
ing TS with CTS, no pooled estimate could be calculated. 
The number of studies, again, is too small to properly assess 
publication bias or perform subgroup analysis.
Differences in survival between different specialties 
were evaluated in two studies, one of which showed a sig-
nificant difference both when comparing GS with CTS and 
when comparing GS with TS.23,29 Both studies met the inclu-
sion criteria for the meta-analysis. Both adjusted for age, 
sex, and tumor characteristics; one also adjusted for comor-
bidity and treatment differences, the other, for other hospital 
characteristics.
Figure 7 shows the forest plot of the included studies. In 
the meta-analysis, a pooled estimated effect size was detected 
in favor of TS over GS, but this effect did not reach statistical 
significance (HR 0.86; CI 0.74–1.00). This result was very 
homogeneous (I2 = 28). The number of studies is too small to 
properly assess publication bias or perform subgroup analysis.
DISCUSSION
This study is the first meta-analysis on the effect of 
surgeon specialty and of procedural volume on postoperative 
FIGURE 4.  Forest plot of the 
included studies in the meta-analysis 
on hospital volume and survival of 
lung resections for cancer. Study 
name, name first author (resection 
type if specific odds ratios available); 
Year, year of publication; Low, high-
est annual volume of low-volume 
category; High, lowest annual 
volume of high-volume category; CI, 
confidence interval.
TABLE 4. Sensitivity Analysis of the Included Studies on 
Hospital Volume and Survival with Hazard Ratios as Effect Size
Factor Subgroup N OR CI p Value
Datasource 0.961
Administrative 3 0.93 0.79–1.10
Clinical 4 0.93 0.79–1.09
Comorbidity 0.003
Not adjusted 3 1.15 0.98–1.34
Adjusted 4 0.88 0.81–0.95
Urgency 0.472
Not adjusted 5 0.96 0.83–1.12
Adjusted 2 0.88 0.72–1.07
Tumor stage 0.127
Not adjusted 1 0.64 0.39–1.05
Adjusted 6 0.95 0.86–1.05
This (two-sided) p value is the result of the mixed-effects analysis and tells us 
whether there is a statistically significant difference in the effect between subgroups.
Bold indicates statistical significance.
N, number of studies; OR, odds ratio; CI, confidence interval; I2, result of I square 
test on heterogeneity of study results.8
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mortality and long-term survival after lung resections for can-
cer. Only a minority of the increasing number of published 
studies met our strict inclusion criteria for methodologi-
cal quality. We found that hospital volume has a significant 
inverse relationship with postoperative mortality, although 
moderate heterogeneity among studies exists. A cutoff value 
for hospital volume could not be identified.
The effect of hospital volume on survival only reached 
significance in the subgroup of these very heterogeneous 
studies, which adjusted for comorbidity (Table 4). This sug-
gests that high-volume hospitals tend to treat more patients 
with multiple comorbidities, which influences the overall sur-
vival in these hospitals.
The pooled-effect estimate of surgeon volume on mor-
tality did not reach significance (very heterogeneous), sug-
gesting that outcome depends more on hospital setting and 
team performance than on volume of individual surgeons. 
Specific thoracic training, however, is of significant impor-
tance. Postoperative mortality and survival rates are signifi-
cantly in favor of CTS and TS when compared with GS (very 
homogeneous).
The available evidence has limitations that cannot be 
ignored. Our review confirms that most studies are obser-
vational, retrospective, and based on administrative data 
collected for other purposes, instead of carefully designed 
comparative studies (Table 2). However, we did not observe 
FIGURE 5.  Forest plot of the 
included studies in the meta-analysis 
on surgeon volume and postopera-
tive mortality of lung resections for 
cancer. Year, year of publication; Low, 
highest annual volume of low-vol-
ume category; High, lowest annual 
volume of high-volume category; CI, 
confidence interval.
FIGURE 6. A and B, Forest plot of 
the included studies in the meta-
analysis on surgeon specialty and 
postoperative mortality of lung resec-
tions for cancer. A, General surgeon 
versus general thoracic surgeon. B, 
General surgeon versus  cardiotho-
racic surgeon. GS, general surgeon; 
TS, general thoracic surgeon; CTS, 
cardiothoracic surgeon; Year, year of 
publication; Low, highest volume of 
low-volume category; High, lowest 
annual volume of high -volume cat-
egory; CI, confidence interval.
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significantly different effect sizes among studies using clini-
cal data and those using administrative data. Large variation 
was observed in demographical, geographical, and epide-
miological factors and in standards of care and definitions 
of surgeon specialties. Awareness of these differences in 
training and certification of “specialized” surgeons is impor-
tant in interpreting these results. In the Dutch situation, for 
instance, a growing number of GSs have had specialist train-
ing in lung resections, which should qualify them as general 
TSs.23
Substantial heterogeneity was identified in evaluating 
studies’ methodological quality. The choice of volume catego-
ries was extremely diverse but seldom explained. The vari-
ety in cutoff values made it impossible to identify a minimal 
hospital volume with regression analysis, despite looking for 
the biggest difference by comparing the highest- and lowest-
volume category from each article.
Apart from the methodological shortcomings men-
tioned above, volume-outcome studies have other important 
limitations. In only few studies, data have been corrected 
for (other) provider characteristics, such as the available 
infrastructure, teaching or academic status, experience with 
other high-risk operations, expertise in multimodality cancer 
treatments, a hospital’s budget, focus and/or referral bias.17,18  
Also, in almost all studies, only the resected patients were 
analyzed. Essential data on patient selection and resection 
rates are missing; therefore, the effect of procedural volume or 
surgeon specialty on the ability to provide appropriate surgi-
cal care for more challenging patients remains unclear. Low-
volume centers might predominantly select a more favorable 
patient group (lower stage and less comorbidity), thus influ-
encing their outcome. The question of whether this clinically 
more favorable patient group would also benefit from referral 
to high-volume centers could not be assessed in this meta-
analysis. These factors are often related to, but not identical 
with, procedural volume.
In the Netherlands the Quality of Cancer Care task force 
of the Dutch Cancer Society has recently proposed to concen-
trate specific cancer treatments in hospitals that meet a set of 
criteria.30 The Dutch Surgical Society set the criteria for lung 
cancer surgery.31 These criteria focus not only on procedural 
volume, but also on the available infrastructure, specialization, 
and outcome measures, which should be reported by individ-
ual institutions.32 Careful analysis of audit data retrieved from 
different hospitals that vary in patterns of care and outcomes 
might identify ways to improve lung cancer treatment more 
than merely enforcing volume criteria.33–35 In our opinion, 
policy makers should bear this in mind when efforts are made 
to centralize complex high-risk surgical procedures.
In conclusion, this meta-analysis has shown that higher 
procedural volume is associated with better outcomes in lung 
cancer surgery. Annual hospital volume seems more impor-
tant than the volume of individual surgeons. Surgeon specialty 
is also of significant importance. Concentration of lung can-
cer surgery could lead to a decrease in postoperative mortality 
and a better overall survival, although there is no evidence 
for a specific annual volume cutoff. Evaluation of individual 
institutions in a national audit program might help elucidate 
the influence of individual quality-of-care parameters, includ-
ing hospital volume, on outcome, and provide better param-
eters to help improve surgical cancer care.
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